AMHR2 and cartilage-hair hypoplasia: To date, only four AMH or AMHR2 heterozygous variants have been described in a cohort of 136 CHH patients, although the experimental evidence supports the fact that the perturbation of the AMH/AMHR2 pathway can underlie CHH pathogenesis [220].